{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:06:52Z","timestamp":1787504812876,"version":"build-2736575974"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1093\/humrep\/dep436","type":"journal-article","created":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T22:19:58Z","timestamp":1260915598000},"page":"683-689","source":"Crossref","is-referenced-by-count":122,"title":["Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)"],"prefix":"10.1093","volume":"25","author":[{"given":"Trifon G.","family":"Lainas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis A.","family":"Sfontouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis Z.","family":"Zorzovilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Petsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"Lainas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Alexopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios M.","family":"Kolibianakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,15]]},"reference":[{"key":"key\n\t\t\t\t20170515120445_DEP436C1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1472-6483(10)60339-2","article-title":"A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS","volume":"15","author":"Aboulghar","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170515120445_DEP436C3","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study","volume":"50","author":"Bahceci","year":"2005","journal-title":"J Reprod Med"},{"key":"key\n\t\t\t\t20170515120445_DEP436C28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0015-0282(97)00542-6","article-title":"Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program","volume":"69","author":"Barash","year":"1998","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170515120445_DEP436C4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/oxfordjournals.humrep.a138260","article-title":"The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features","volume":"8","author":"Delvigne","year":"1993","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170515120445_DEP436C5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170515120445_DEP436C7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"key\n\t\t\t\t20170515120445_DEP436C8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","article-title":"GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis","volume":"13","author":"Griesinger","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170515120445_DEP436C9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170515120445_DEP436C10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2002-020788","article-title":"A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol","volume":"88","author":"Hohmann","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170515120445_DEP436C11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","article-title":"Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study","volume":"19","author":"Hwang","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170515120445_DEP436C12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1472-6483(10)61870-6","article-title":"Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF\/ICSI","volume":"7","author":"Kolibianakis","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170515120445_DEP436C13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.0001-6349.2004.00480.x","article-title":"GnRH antagonists in poor responders","volume":"83","author":"Kolibianakis","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t20170515120445_DEP436C14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170515120445_DEP436C15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/humupd\/dmm008","article-title":"Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis","volume":"13","author":"Kolibianakis","year":"2007","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170515120445_DEP436C16","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.fertnstert.2006.12.058","article-title":"Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone","volume":"88","author":"Kolibianakis","year":"2007","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170515120445_DEP436C17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10815-008-9249-7","article-title":"Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study","volume":"25","author":"Kurzawa","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20170515120445_DEP436C18","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/humrep\/dei106","article-title":"In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF","volume":"20","author":"Lainas","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170515120445_DEP436C19","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/dem033","article-title":"Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development","volume":"22","author":"Lainas","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170515120445_DEP436C20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170515120445_DEP436C21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1472-6483(10)60090-9","article-title":"Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index","volume":"18","author":"Orvieto","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170515120445_DEP436C22","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/humrep\/dei074","article-title":"Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome","volume":"20","author":"Ragni","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170515120445_DEP436C23","first-page":"131","article-title":"Classification, pathophysiology and management of ovarian hyperstimulation syndrome","volume-title":"In-Vitro Fertilization and Assisted Reproduction","author":"Rizk","year":"1999"},{"key":"key\n\t\t\t\t20170515120445_DEP436C25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.fertnstert.2004.05.005","article-title":"Ovarian hyperstimulation syndrome","volume":"82","author":"The Practice Committee of the American Society for Reproductive Medicine","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170515120445_DEP436C26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170515120445_DEP436C27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","author":"The Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","journal-title":"Fertil Steril"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,18]],"date-time":"2017-06-18T22:49:06Z","timestamp":1497826146000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/dep436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,15]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,12,15]]},"published-print":{"date-parts":[[2010,3]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dep436","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2881962.2550061","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.2881962.3408056","asserted-by":"object"}]},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,15]]}}}